Ketorolac Tromethamine Ophthalmic Solution Recalled for Sterility Risk
Apotex Corp. is recalling Ketorolac Tromethamine Ophthalmic Solution 0.5% due to lack of assurance of sterility. The recall affects 87,840 bottles distributed nationwide.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class II recall as stated by the agency. Lack of sterility assurance in an ophthalmic drug product presents a significant risk of adverse health consequences, including infection. Class II recalls with such risk warrant a Severe classification.
Plain-English summary
Apotex Corp. is recalling Ketorolac Tromethamine Ophthalmic Solution, 0.5%, 10 mL (NDC 60505-1003-2) due to lack of assurance of sterility. The recalled product was manufactured by Apotex Inc. in Toronto, Ontario, Canada, and manufactured for Apotex Corp. in Weston, Florida. The recall involves 87,840 bottles distributed nationwide in the United States.
The affected batch is TZ1236 with an expiration date of November 30, 2025. Ketorolac Tromethamine is a prescription ophthalmic (eye) medication.
Patients who have received this product should contact their healthcare provider or pharmacist. Distributors and healthcare facilities should stop dispensing the recalled product and return it to the manufacturer.
The recalled product
- Product
- KETOROLAC TROMETHAMINE (KETOROLAC TROMETHAMINE)
- Brand
- KETOROLAC TROMETHAMINE
- Manufacturer
- Apotex Corp.
- Hazard
- sterility-assurance
- contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Batch TZ1236
- Exp Date: 11/30/2025
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · KETOROLAC TROMETHAMINE
- HighInjectable ketorolac tromethamine recalled nationwide for potential cross-contamination
FDA (Drugs) · 2022-08-24
Same category
- SevereChloraPrep One-Step Applicators Recalled for Potential Packaging Seal Defects
FDA (Drugs) · 2026-07-22
- ModerateCAREone Earwax Removal Drops Recalled for Subpotent Active Ingredient
FDA (Drugs) · 2026-07-22
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- ModerateFamily Wellness Carbamide Peroxide Earwax Removal Kit Subpotent Drug
FDA (Drugs) · 2026-07-22
- ModerateNystatin Cream Recall Due to Low Potency Test Results
FDA (Drugs) · 2026-07-22